SCHEMBL4835689

SCHEMBL4835689

CCOc1cc(C=CC(=O)O)ccc1O

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP2A P11388 1/20 0.78
▸ KDM4E B2RXH2 8/20 0.70
▸ CA12 O43570 2/20 0.70
▸ CA1 P00915 2/20 0.70
▸ CA2 P00918 2/20 0.70
▸ CA3 P07451 2/20 0.70
▸ CA4 P22748 2/20 0.70
▸ CA6 P23280 2/20 0.70
▸ CA5A P35218 2/20 0.70
▸ CA7 P43166 2/20 0.70
▸ CA9 Q16790 2/20 0.70
▸ CA14 Q9ULX7 2/20 0.70
▸ CA5B Q9Y2D0 2/20 0.70
▸ PKM P14618 1/20 0.70
▸ CSNK2A2 P19784 1/20 0.70
▸ SNCA P37840 1/20 0.70
▸ CSNK2B P67870 1/20 0.70
▸ CSNK2A1 P68400 1/20 0.70
▸ CSNK2A3 Q8NEV1 1/20 0.70
▸ KMT2A Q03164 5/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31380860 1.00 TOP2A (0.78) TOP2AKDM4ECA12CA1CA2
SCHEMBL4621488 1.00 TOP2A (0.78) TOP2AKDM4ECA12CA1CA2
SCHEMBL10870003 0.90 TOP2A (0.64) TOP2AKDM4ECA12CA1CA2
SCHEMBL7252136 0.88 KDM4E (0.73) TOP2AKDM4ECA12CA1CA2
SCHEMBL4621755 0.88 KDM4E (0.73) TOP2AKDM4ECA12CA1CA2
Ethyl Curcumin SCHEMBL8965258 0.88 TOP2A (1.00) TOP2AKDM4ECA12CA1CA2
SCHEMBL4935432 0.88 TOP2A (0.78) TOP2AKDM4ECA12CA1CA2
Ethyl Curcumin SCHEMBL8965263 0.88 TOP2A (1.00) TOP2AKDM4ECA12CA1CA2
SCHEMBL4935429 0.88 TOP2A (0.78) TOP2AKDM4ECA12CA1CA2
SCHEMBL7247313 0.88 KDM4E (0.84) TOP2AKDM4ECA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0633021-B1 Chondroprotective agents KUREHA CHEMICAL IND CO LTD (JP) 1998-05-06 — — EP claimed
US-5621009-A ADMINISTERING ALKOXY- AND HYDROXY-SUBSTITUTED CINNAMIC ACIDS FOR TREATMENT AND/OR PREVENTION OF CARTILEGE DISEASES KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1997-04-15 — — US claimed
EP-0633021-A1 Chondroprotective agents KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1995-01-11 — — EP claimed
EP-0166542-B1 TRITERPENYL ESTERS OF ORGANIC ACIDS, PROCESS FOR THEIR PRODUCTION, AND HYPOLIPIDEMIC AGENTS COMPOSED OF THEM AMANO PHARMACEUTICAL CO., LTD. (JP) 1990-08-08 — — EP claimed
US-4748161-A Triterpenyl esters of organic acids and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1988-05-31 — — US claimed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 — — EP claimed
JP-7025759-A — — None — — JP disclosed
JP-1013018-A — — None — — JP disclosed
US-20250129007-A1 PROCESS FOR PREPARING P-HYDROXYCINNAMIC ACID SPECIALTY OPERATIONS FRANCE (FR) 2025-04-24 — — US disclosed
EP-4469428-A1 PROCESS FOR PREPARING P-HYDROXYCINNAMIC ACID SPECIALTY OPERATIONS FRANCE (FR) 2024-12-04 — — EP disclosed
WO-2023144108-A1 PROCESS FOR PREPARING P-HYDROXYCINNAMIC ACID RHODIA OPERATIONS (FR) 2023-08-03 — — WO disclosed
CN-113880695-A Preparation method of 4-vinylphenol compound 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 2022-01-04 — — CN disclosed
CN-108473484-B Compounds useful as TRPM8 modulators 弗门尼舍公司 2021-06-29 — — CN disclosed
US-5621009-A ADMINISTERING ALKOXY- AND HYDROXY-SUBSTITUTED CINNAMIC ACIDS FOR TREATMENT AND/OR PREVENTION OF CARTILEGE DISEASES KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1997-04-15 — — US disclosed
JP-H0725759-A AGENT FOR PROTECTING CARTILAGE KUREHA CHEM IND CO LTD 1995-01-27 — — JP disclosed
EP-0633021-A1 Chondroprotective agents KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) 1995-01-11 — — EP disclosed
EP-0166542-B1 TRITERPENYL ESTERS OF ORGANIC ACIDS, PROCESS FOR THEIR PRODUCTION, AND HYPOLIPIDEMIC AGENTS COMPOSED OF THEM AMANO PHARMACEUTICAL CO., LTD. (JP) 1990-08-08 — — EP disclosed
JP-S6413018-A SKIN-BEAUTIFYING COSMETIC POLA CHEM IND INC 1989-01-17 — — JP disclosed
US-4748161-A Triterpenyl esters of organic acids and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1988-05-31 — — US disclosed
EP-0166542-A2 Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them AMANO PHARMACEUTICAL CO., LTD. (JP) 1986-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129007-A1 PROCESS FOR PREPARING P-HYDROXYCINNAMIC ACID HPD, HAAO, PAH TOP2A 2936/4885KDM4E 3192/4885CA12 1222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback